Mark Roskey Biography and Net Worth

SVP of Quanterix

Mark joined Quanterix in mid 2014 as the Vice President and General Manager of Applications and Reagents. He has more than 25 years of experience in the life science industry focusing on product R&D, applications development, strategic sales and marketing, and overall business management for complex biological solutions and automated instrument systems. He comes to Quanterix from PerkinElmer’s LST division where he was VP/GM of the America’s Sales and Service organization. Prior to PerkinElmer, Mark held senior level commercial and technical positions at Caliper Life Sciences, which was acquired by PerkinElmer in 2011. Mark holds a Ph.D. in Microbiology from the University of Notre Dame and completed a postdoctoral fellowship in Molecular Immunobiology at the Harvard Medical School.

What is Mark T. Roskey's net worth?: The estimated net worth of Mark T. Roskey is at least $262,318.75 as of April 1st, 2022. Dr. Roskey owns 22,325 shares of Quanterix stock worth more than $262,319 as of November 23rd. This net worth estimate does not reflect any other investments that Dr. Roskey may own. Additionally, Dr. Roskey receives an annual salary of $495,030.00 as SVP at Quanterix. Learn More about Mark T. Roskey's net worth.
How old is Mark T. Roskey?: Dr. Roskey is currently 64 years old. There are 7 older executives and no younger executives at Quanterix. The oldest executive at Quanterix is Dr. David R. Walt Ph.D., Co-Founder, Chairman of Scientific Advisory Board & Independent Director, who is 71 years old. Learn More on Mark T. Roskey's age.
What is Mark T. Roskey's salary?: As the SVP of Quanterix Co., Dr. Roskey earns $495,030.00 per year. There are 2 executives that earn more than Dr. Roskey. The highest earning executive at Quanterix is Dr. Masoud Toloue Ph.D., President, CEO & Director, who commands a salary of $957,030.00 per year. Learn More on Mark T. Roskey's salary.
How do I contact Mark T. Roskey?: The corporate mailing address for Dr. Roskey and other Quanterix executives is 900 MIDDLESEX TURNPIKE, BILLERICA MA, 01821. Quanterix can also be reached via phone at (617) 301-9400 and via email at [email protected]. Learn More on Mark T. Roskey's contact information.
Has Mark T. Roskey been buying or selling shares of Quanterix?: Mark T. Roskey has not been actively trading shares of Quanterix over the course of the past ninety days. Learn More on Mark T. Roskey's trading history.
Who are Quanterix's active insiders?: Quanterix's insider roster includes Amol Chaubal (CFO), Marijn Dekkers (Director), David Duffy (SVP), John Fry (General Counsel), E Hrusovsky (CEO), Dawn Mattoon (VP), and Mark Roskey (SVP). Learn More on Quanterix's active insiders.
Are insiders buying or selling shares of Quanterix?: During the last year, Quanterix insiders bought shares 1 times. They purchased a total of 47,000 shares worth more than $624,630.00. During the last year, insiders at the sold shares 2 times. They sold a total of 2,500 shares worth more than $60,025.00. The most recent insider tranaction occured on August, 20th when Director David R Walt bought 47,000 shares worth more than $624,630.00. Insiders at Quanterix own 6.9% of the company. Learn More about insider trades at Quanterix.
Information on this page was last updated on 8/20/2024.

Mark T. Roskey Insider Trading History at Quanterix

Mark T. Roskey Buying and Selling Activity at Quanterix

Quanterix Company Overview

Quanterix Corporation, a life sciences company, engages in development and marketing of digital immunoassay platforms that advances precision health for life sciences research and diagnostics in North America, Europe, the Middle East, Africa, and the Asia Pacific regions. The company offers HD-X instrument, a protein detection platform; and SR-X instrument that enables researchers to apply Simoa detection in an expanded range of applications. It also provides SP-X instrument that is based on Simoa planar array technology for the measurement of multiplex chemiluminescent immunoassays. The company's products include assays include all components required to run enzyme-based immunoassay, such as beads, capture and detector reagents, and enzyme reagents and substrate; and replacement parts, reagents, and antibodies. In addition, it offers contract research services, including sample testing, homebrew assay development, custom assay development, lucent diagnostic, and LDT testing services. The company primarily operates in the areas of neurology, oncology, cardiology, infectious diseases, and inflammation. It sells its products for the life science research sector primarily to laboratories associated with academic and governmental research institutions, as well as pharmaceutical, biotechnology, and contract research companies through a direct field sale, support organizations, and distributors or sales agents. The company was formerly known as Digital Genomics, Inc. and changed its name to Quanterix Corporation in August 2007. Quanterix Corporation was incorporated in 2007 and is headquartered in Billerica, Massachusetts.

Today's Range

Now: $11.75

$11.58

$12.12

50 Day Range

MA: $12.86

$11.02

$15.49

2 Week Range

Now: $11.75

$10.50

$29.70

Volume

256,544 shs

Average Volume

476,778 shs

Market Capitalization

$450.97 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.36

Election warning coming true…

From Porter & Company | Ad

If you missed it, my emergency election broadcast is now available - watch it before it's too late.

Click here to watch it now.

Mark Roskey Biography and Net Worth

What is Mark T. Roskey's net worth?

How old is Mark T. Roskey?

What is Mark T. Roskey's salary?

How do I contact Mark T. Roskey?

Has Mark T. Roskey been buying or selling shares of Quanterix?

Who are Quanterix's active insiders?

Are insiders buying or selling shares of Quanterix?